🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Intravitreal ranibizumab alone was Compared to adding dexamethasone to rani...
Status
Completed
Location
Khaled G Abueleinen
Start Date
2020-07-01
Trial ID
NCT05271539
Treatments Being Tested
To evaluate, specifically within the Canadian medical environment, the effi...
Status
Completed
Location
Calgary Retina Consultants
Start Date
2010-07
Trial ID
NCT01135914
Treatments Being Tested
Antagonists of the vascular endothelial growth factor (VEGF) pathway are ef...
Status
Completed
Location
The Retina Institute
Start Date
2011-09
Trial ID
NCT01428388
Treatments Being Tested
The study was designed to assess the efficacy and safety of Lucentis® (rani...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2014-05-19
Trial ID
NCT02032173
Treatments Being Tested
Ranibizumab has proven to be of benefit to improve the perfusion in the ret...
Status
Completed
Location
New England Retina Associates
Start Date
2010-07
Trial ID
NCT01251978
Treatments Being Tested
This is an open-label, multicenter, extension study of intravitreally admin...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT01442064
Treatments Being Tested
The study is intended to characterize the clinical benefit regarding safety...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-05
Trial ID
NCT01580020
Treatments Being Tested
This study will assess corneal endothelial cells in participants with nAMD ...
Status
Recruiting
Location
Barnet Dulaney Perkins Eye Center
Start Date
2021-12-14
Trial ID
NCT04853251
Treatments Being Tested
This multiple-center, multiple-dose and regimen, randomized, double-masked ...
Status
Completed
Location
Associated Retina Consultants
Start Date
2015-08-11
Trial ID
NCT02484690
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness, safety, and PRO...
Status
Recruiting
Location
Medizinische Universität Innsbruck
Start Date
2025-11-27
Trial ID
NCT06847542
Treatments Being Tested